Prices of traditional Chinese medicine cordyceps (“caterpillar fungus”) surge out of control; US$19/kg in 1982 to US$142,680/kg

Prices of caterpillar fungus surge out of control

Staff Reporter

  • 2013-03-07

Prices of cordyceps — a traditional Chinese medicine better known in English as caterpillar fungus — have flown skywards in recent years as new buyers in the market purchase in unusually high quantities, the Shanghai-based First Financial Daily reported.

Cordyceps are caterpillars infected with a parasitic fungus, which kills its host in the end. They are mainly collected in the mountains of the frigid Tibetan Plateau during a period of over two months beginning April 20.

With researchers discovering more medicinal value in cordyceps after the 1990s, prices of the top-class medical fungus have skyrocketed from 1982’s 120 yuan (US$19) per kilogram to 1993’s 3,000 yuan (US$482) per kilogram.

Its prices shot up further to 16,000 yuan (US$2,571) per kilogram in 2003, when SARS hit China. As of last year, there were no signs of slowing up as they touched 888,000 yuan (US$142,680) per kilogram in 2012, the newspaper said,

A buyer at the Hehuachi Chinese herb marketplace in Chengdu, the largest cordyceps wholesale market in southeast China, told the newspaper that while climate has affected the harvest in recent years, hoarding by several buyers had also led to a sharp decline in the circulation of the medical fungus in the market.

Moreover, there has been an increasing number of buyers during the last two years, making purchases in tons, instead of the usual kilograms, the buy said.

According to the buyer, the amount of cordyceps traded in the market in 2012 had halved from a year earlier.

Interest from drug companies in cordyceps increased following an announcement by China’s State Food and Drug Administration last August about beginning a trial program on the use of the fungus in health supplements.

Qinghai Chuntian Medical Resource Utilization was one of the major buyers of the fungus. The amount it purchased in 2012 was equivalent to a third of the annual output of Qinghai province, according to the Chengdu-based buyer.

The strong demand for cordyceps has also ushered in the counterfeits. Buyers now have to watch out for fungus with slivers of cement or lead added to inflate the weight. The Qinghai provincial government has introduced other regulatory measures to curb this practice.

A strict national standard is required to thoroughly address the problems of the market.

“Folk medicine is usually grown in small amounts, since it is about using local resources. Those growing in the wild must be sustainable,” said Lei Jufang, chairman of a company called Cheezheng, which specializes in Tibetan medicine.

Lei said the surging prices of cordyceps deviate from the purpose of traditional medicine and the value of the medical fungus.

Unknown's avatarAbout bambooinnovator
Kee Koon Boon (“KB”) is the co-founder and director of HERO Investment Management which provides specialized fund management and investment advisory services to the ARCHEA Asia HERO Innovators Fund (www.heroinnovator.com), the only Asian SMID-cap tech-focused fund in the industry. KB is an internationally featured investor rooted in the principles of value investing for over a decade as a fund manager and analyst in the Asian capital markets who started his career at a boutique hedge fund in Singapore where he was with the firm since 2002 and was also part of the core investment committee in significantly outperforming the index in the 10-year-plus-old flagship Asian fund. He was also the portfolio manager for Asia-Pacific equities at Korea’s largest mutual fund company. Prior to setting up the H.E.R.O. Innovators Fund, KB was the Chief Investment Officer & CEO of a Singapore Registered Fund Management Company (RFMC) where he is responsible for listed Asian equity investments. KB had taught accounting at the Singapore Management University (SMU) as a faculty member and also pioneered the 15-week course on Accounting Fraud in Asia as an official module at SMU. KB remains grateful and honored to be invited by Singapore’s financial regulator Monetary Authority of Singapore (MAS) to present to their top management team about implementing a world’s first fact-based forward-looking fraud detection framework to bring about benefits for the capital markets in Singapore and for the public and investment community. KB also served the community in sharing his insights in writing articles about value investing and corporate governance in the media that include Business Times, Straits Times, Jakarta Post, Manual of Ideas, Investopedia, TedXWallStreet. He had also presented in top investment, banking and finance conferences in America, Italy, Sydney, Cape Town, HK, China. He has trained CEOs, entrepreneurs, CFOs, management executives in business strategy & business model innovation in Singapore, HK and China.

Leave a comment